Best CRT - D Hospitals in Turkey

Choosing Medicana Bursa Hospital for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 2017, the JCI, ISO hospital in Bursa, Turkey has 300 beds and provides specialised cardiac services.

CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.

Acibadem Maslak Hospital is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 2009, the JCI hospital is situated in Istanbul, Turkey and has 364 beds.

CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.

Acibadem Fulya Hospital offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 2006, the JCI hospital is located in Istanbul, Turkey and has 138 beds, providing comprehensive care for local and international patients.

CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.

At Acibadem Hospital Taksim, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 2015, this JCI hospital in Istanbul, Turkey has 99 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.

At Acibadem Bakirkoy Hospital, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 2000, this JCI hospital in Istanbul, Turkey has 102 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.

Guven Hospital is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 1975, the GHA hospital is situated in Ankara, Turkey and has 254 beds.

CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.

Biruni University Hospital is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 2016, the JCI hospital is situated in Istanbul, Turkey and has 617 beds.

CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.

Medipol Mega University Hospital offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 2012, the JCI hospital is located in Istanbul, Turkey and has 810 beds, providing comprehensive care for local and international patients.

CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.

At Medical Park Fatih Hospital, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 2007, this JCI hospital in Istanbul, Turkey has 246 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.

Choosing Medical Park Bahcelievler Hospital for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 2015, the JCI hospital in Istanbul, Turkey has 242 beds and provides specialised cardiac services.

CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.

Medstar Antalya Hospital offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 2009, the JCI hospital is located in Ankara, Turkey and has 124 beds, providing comprehensive care for local and international patients.

CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.

Medicana Camlica Hospital is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 1999, the ISO, JCI hospital is situated in Istanbul, Turkey and has 113 beds.

CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.

Memorial Sisli Hospital provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2000, the JCI, NABH hospital is located in Istanbul, Turkey, and operates 252 beds, equipped with modern healthcare infrastructure.

CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.

Hisar Intercontinental Hospital is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 2005, the JCI hospital is situated in Istanbul, Turkey and has 170 beds.

CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.

Medical Park Karadeniz Hospital provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2007, the JCI hospital is located in Trabzon, Turkey, and operates 112 beds, equipped with modern healthcare infrastructure.

CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.